Not applicableStudy completedNCT01615653What this trial is testingEUS Guided Celiac NeurolysisWho this might be right forPancreatic Cancer Pain Mayo Clinic 110
Early research (Phase 1)UnknownNCT04258072What this trial is testingVactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.Who this might be right forPancreas Cancer Samsung Medical Center 24
Early research (Phase 1)Study completedNCT04106856What this trial is testingLosartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic CancerWho this might be right forBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more University of Utah 22
Not applicableLooking for participantsNCT05737953What this trial is testingConstruction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid SamplesWho this might be right forPancreatic NeoplasmsDNA MethylationProteome Zhaoshen Li 100
Testing effectiveness (Phase 2)Ended earlyNCT05169437What this trial is testingNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsWho this might be right forSolid TumorBreast TumorColon Tumor, Malignant+9 more Tempus AI 22
Not applicableUnknownNCT04189393What this trial is testingMicrobiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal SurgeryWho this might be right forGastrointestinal CancerColorectal CancerPancreatic Cancer+8 more Radboud University Medical Center 60
Early research (Phase 1)Ended earlyNCT06466187What this trial is testingSGN-MesoC2 in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more Seagen, a wholly owned subsidiary of Pfizer 19
Not applicableUnknownNCT02292914What this trial is testingProspective Analysis of Robot-Assisted SurgeryWho this might be right forEsophageal CancerGastric CancerPancreatic Cancer+7 more Instituto do Cancer do Estado de São Paulo 1,120
Testing effectiveness (Phase 2)Study completedNCT02131493What this trial is testingS-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic CancerWho this might be right forPancreatic Cancer Zhejiang University 80
Large-scale testing (Phase 3)Study completedNCT03984214What this trial is testingEfficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Early research (Phase 1)WithdrawnNCT05043987What this trial is testingDose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced CancersWho this might be right forPancreatic CancerGastric Cancer Conjupro Biotherapeutics, Inc.
Not applicableUnknownNCT05580887What this trial is testingIntestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer PatientsWho this might be right forBreast CancerPancreas Cancer Moscow Clinical Scientific Center 35
Testing effectiveness (Phase 2)Study completedNCT02080221What this trial is testingBrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialWho this might be right forMetastatic Pancreatic Cancer Brown University 50
Testing effectiveness (Phase 2)Study completedNCT00125021What this trial is testingTarceva and Capecitabine for Pancreatic CancerWho this might be right forPancreatic CancerNeoplasm Metastasis Dana-Farber Cancer Institute 32
Early research (Phase 1)Ended earlyNCT06194877What this trial is testingInvestigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersWho this might be right forColorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers MapKure, LLC 13
Large-scale testing (Phase 3)Study completedNCT00471146What this trial is testingStudy Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.Who this might be right forCarcinoma, Pancreatic Ductal Pfizer 630
Not applicableStudy completedNCT03808272What this trial is testingAXIOS CHINA (E7148)Who this might be right forPancreatic Pseudocyst and Walled-off Necrosis Boston Scientific Corporation 31
Testing effectiveness (Phase 2)Study completedNCT00003546What this trial is testingGemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Alliance for Clinical Trials in Oncology 43
Not applicableActive Not RecruitingNCT04427761What this trial is testingThe Life Changes Experienced by Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Memorial Sloan Kettering Cancer Center 55
Early research (Phase 1)Study completedNCT00039403What this trial is testingUCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more National Cancer Institute (NCI) 30